Advancing Breast Cancer Research: Lambda & Novum's Commitment to Patient-Centric Trials

Advancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials

• Post author:Dipesh Chodvadia
• Post published:November 30, 2023
• Post category:Case-Study

CASE-STUDY

Continue ReadingAdvancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials

CASE-STUDY: Advancing Pediatric Clinical Trials Overcoming Challenges in the Clinical Trial of Pegfilgrastim for Rhabdomyosarcoma & Wilms' Tumor

Advancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim

• Post author:Dipesh Chodvadia
• Post published:November 30, 2023
• Post category:Case-Study

CASE-STUDY

Continue ReadingAdvancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim

Overcoming Challenges in a Multicenter Oncology Clinical Trial - Lambda Therapeutic Research - Top CRO - Leading CRO

Overcoming Challenges in a Multicenter Oncology Clinical Trial

• Post author:Dipesh Chodvadia
• Post published:November 22, 2023
• Post category:Case-Study

CASE-STUDY

Continue ReadingOvercoming Challenges in a Multicenter Oncology Clinical Trial

Overcoming Challenges in a Multicenter Oncology Clinical Trial - Lambda Therapeutic Research - Top CRO - Leading CRO

Overcoming Challenges in a Multicenter Oncology Clinical Trial: Study on Bioequivalence Assessment of Doxorubicin Hydrochloride Liposome Injection

• Post author:Dipesh Chodvadia
• Post published:August 12, 2023
• Post category:Blog/Late Phase

Blog

Continue ReadingOvercoming Challenges in a Multicenter Oncology Clinical Trial: Study on Bioequivalence Assessment of Doxorubicin Hydrochloride Liposome Injection

Lambda Therapeutic Research successfully clears another EMA Inspection for two PK studies in Oncology on Metastatic Breast Cancer and Ovarian Cancer patients

• Post author:Dipesh Chodvadia
• Post published:December 11, 2021
• Post category:News

NEWS

Continue ReadingLambda Therapeutic Research successfully clears another EMA Inspection for two PK studies in Oncology on Metastatic Breast Cancer and Ovarian Cancer patients